Beatriz Castelo

La Paz, MD 28046, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

Journal: International journal of molecular sciences
Published: January 26, 2026

Genome-wide CRISPR screen identifies AMBRA1 as a potential biomarker of response to platinum-based therapies in oral squamous cell carcinomas.

Genome-wide CRISPR screen identifies AMBRA1 as a potential biomarker of response to platinum-based therapies in oral squamous cell carcinomas.

Journal: iScience
Published: January 12, 2026

SEOM-TTCC clinical guidelines for the treatment of head and neck cancer (2025).

SEOM-TTCC clinical guidelines for the treatment of head and neck cancer (2025).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 08, 2026

An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).

An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).

Journal: Oral oncology
Published: November 09, 2025

An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).

An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).

Journal: Oral oncology
Published: November 09, 2025

Clinical and treatment patterns of advanced and radioiodine-refractory differentiated thyroid cancer. ERUDIT study.

Clinical and treatment patterns of advanced and radioiodine-refractory differentiated thyroid cancer. ERUDIT study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 01, 2025

Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.

Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.

Journal: Nature communications
Published: August 18, 2025

DUSP1 and SOX2 expression determine squamous cell carcinoma of the salivary gland progression.

DUSP1 and SOX2 expression determine squamous cell carcinoma of the salivary gland progression.

Journal: Scientific reports
Published: January 17, 2024

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs.

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs.

Journal: Cancer metastasis reviews
Published: August 20, 2023

Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study.

Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study.

Journal: European thyroid journal
Published: June 13, 2022

Long-term complete remission of metastatic adrenocortical carcinoma.

Long-term complete remission of metastatic adrenocortical carcinoma.

Journal: Hormone molecular biology and clinical investigation
Published: February 06, 2022

Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios.

Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios.

Journal: Cancer medicine
Published: January 21, 2022
Showing 1-12 of 45

Last Updated: 09/26/2026